LINDSAY DOWNING: Open Payments
NPI 1235680323 · BARTLESVILLE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 42 payments from 12 companies in 2025. Trend: 2023 $251 · 2024 $428 · 2025 $1,097
Food & beverage: $919Travel & lodging: $178
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 4 | $387 |
| E.R. Squibb & Sons, L.L.C. | 17 | $321 |
| Amgen Inc. | 7 | $120 |
| SCPHARMACEUTICALS INC. | 3 | $55 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Innovation Technologies Inc | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $23 |
Products named: CAMZYOS, REPATHA, FUROSCIX, LifeVest, Kerendia, LEQVIO, IRRISEPT, ELIQUIS.
Industry payments across OK — which companies pay providers there.
